AI assistant
Sending…
Nkarta, Inc. — Director's Dealing 2023
Jun 22, 2023
33926_dirs_2023-06-22_37a5db6f-6a76-4b2d-8636-1875bce62f66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nkarta, Inc. (NKTX)
CIK: 0001787400
Period of Report: 2023-06-20
Reporting Person: Shook David (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-20 | Common Stock | S | 439 | $4.85 | Disposed | 61863 | Direct |
Footnotes
F1: Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
F2: Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2023.
More from Nkarta, Inc.
Capital/Financing Update
2026
Apr 3
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8
Capital/Financing Update
2026
Jan 5